Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Head-to-Head drug battle aims to find best treatment for bipolar depression

NCT ID NCT05913947

First seen Jan 29, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This study compares two medicines, lithium and cariprazine, to see which works better for treating depression in people with bipolar disorder. About 122 adults with bipolar depression will be randomly assigned to take one of the two drugs for 8 weeks. Researchers will measure changes in depression symptoms using a standard rating scale.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION, BIPOLAR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aalborg University Hospital

    RECRUITING

    Aalborg, 9000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.